Human SOCS1/AISIMD/CIS1 ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_003745.2)
Cat. No.: pGMPC001717
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human SOCS1/AISIMD/CIS1 Non-Viral expression plasmid (overexpression vector) for mouse SOCS1 overexpression in unique cell transient transfection and stable cell line development.
Go to
SOCS1/AISIMD products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMPC001717 |
| Gene Name | SOCS1 |
| Accession Number | NM_003745.2 |
| Gene ID | 8651 |
| Species | Human |
| Product Type | Mammalian (Non-Viral Vector) plasmid (overexpression) |
| Insert Length | 636 bp |
| Gene Alias | AISIMD,CIS1,CISH1,JAB,SOCS-1,SSI-1,SSI1,TIP-3,TIP3 |
| Fluorescent Reporter | Null |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGTAGCACACAACCAGGTGGCAGCCGACAATGCAGTCTCCACAGCAGCAGAGCCCCGACGGCGGCCAGAACCTTCCTCCTCTTCCTCCTCCTCGCCCGCGGCCCCCGCGCGCCCGCGGCCGTGCCCCGCGGTCCCGGCCCCGGCCCCCGGCGACACGCACTTCCGCACATTCCGTTCGCACGCCGATTACCGGCGCATCACGCGCGCCAGCGCGCTCCTGGACGCCTGCGGATTCTACTGGGGGCCCCTGAGCGTGCACGGGGCGCACGAGCGGCTGCGCGCCGAGCCCGTGGGCACCTTCCTGGTGCGCGACAGCCGCCAGCGGAACTGCTTTTTCGCCCTTAGCGTGAAGATGGCCTCGGGACCCACGAGCATCCGCGTGCACTTTCAGGCCGGCCGCTTTCACCTGGATGGCAGCCGCGAGAGCTTCGACTGCCTCTTCGAGCTGCTGGAGCACTACGTGGCGGCGCCGCGCCGCATGCTGGGGGCCCCGCTGCGCCAGCGCCGCGTGCGGCCGCTGCAGGAGCTGTGCCGCCAGCGCATCGTGGCCACCGTGGGCCGCGAGAACCTGGCTCGCATCCCCCTCAACCCCGTCCTCCGCGACTACCTGAGCTCCTTCCCCTTCCAGATTTGA |
| ORF Protein Sequence | MVAHNQVAADNAVSTAAEPRRRPEPSSSSSSSPAAPARPRPCPAVPAPAPGDTHFRTFRSHADYRRITRASALLDACGFYWGPLSVHGAHERLRAEPVGTFLVRDSRQRNCFFALSVKMASGPTSIRVHFQAGRFHLDGSRESFDCLFELLEHYVAAPRRMLGAPLRQRRVRPLQELCRQRIVATVGRENLARIPLNPVLRDYLSSFPFQI |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T06800-Ab | Anti-SOCS1 monoclonal antibody |
| Target Antigen | GM-Tg-g-T06800-Ag | SOCS1 protein |
| ORF Viral Vector | pGMLP003452 | Human SOCS1 Lentivirus plasmid |
| ORF Viral Vector | pGMLV000858 | Human SOCS1 Lentivirus plasmid |
| ORF Viral Vector | pGMPC000656 | Human SOCS1 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC001717 | Human SOCS1 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP003452 | Human SOCS1 Lentivirus particle |
| ORF Viral Vector | vGMLV000858 | Human SOCS1 Lentivirus particle |
Target information
| Target ID | GM-T06800 |
| Target Name | SOCS1 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
8651 |
| Gene ID |
102148488 (Equus caballus), 111558242 (Felis catus), 12703 (Mus musculus), 252971 (Rattus norvegicus) 490006 (Canis lupus familiaris), 518795 (Bos taurus), 711180 (Macaca mulatta), 8651 (Homo sapiens) |
| Gene Symbols & Synonyms | SOCS1,Socs1,JAB,Cish1,Cish7,SSI-1,SOCS-1,Socs-1,CIS1,SSI1,TIP3,CISH1,TIP-3,AISIMD |
| Target Alternative Names | AISIMD,CIS1,CISH1,Cish1,Cish7,JAB,JAK-binding protein (JAB),SOCS-1,SOCS1,SSI-1,SSI1,STAT-induced STAT inhibitor 1 (SSI-1),Socs-1,Socs1,Suppressor of cytokine signaling 1,TIP-3,TIP3,Tec-interacting protein 3 (TIP-3) |
| Uniprot Accession |
O15524,O35716,Q9QX78
Additional SwissProt Accessions: O35716,Q9QX78,O15524 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer |
| Disease from KEGG | Osteoclast differentiation, JAK-STAT signaling pathway, Prolactin signaling pathway, Type II diabetes mellitus, Growth hormone synthesis, secretion and action, Toxoplasmosis |
| Gene Ensembl | ENSECAG00000026965, ENSMUSG00000038037, ENSBTAG00000004386, ENSMMUG00000010956, ENSG00000185338 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


